Latest Breaking News On - Division of hematology - Page 7 : comparemela.com

Study identifies disparities in end-of-life care for lung cancer patients

Study identifies disparities in end-of-life care for lung cancer patients
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesGladysm rodriguezAmerican lung associationNorthwestern universityCalifornia office of statewide health planningRoberth lurie comprehensive cancer centerCenters for diseaseDivision of hematologyPacific islanderNorthwestern medicineDisease controlAmerican lungCalifornia cancer registryCalifornia officeStatewide health planningNative american

Dr Cherng on Approvals of Epcoritamab and Glofitamab for R/R DLBCL

Dr Cherng on Approvals of Epcoritamab and Glofitamab for R/R DLBCL
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Hua jay jeff cherngDivision of hematologyColumbia university irving medical centerColumbia universityIrving medical center

TSP May Predict Chemoresistance and Survival Outcomes in Ovarian Cancer

TSP May Predict Chemoresistance and Survival Outcomes in Ovarian Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesEmil louGynecologic oncology groupDivision of hematologyUniversity of minnesota medical schoolCancer genome atlasMinnesota medicalNorth america

Dr Beckermann on Targeting TREM2 in the Treatment of ccRCC

Dr Beckermann on Targeting TREM2 in the Treatment of ccRCC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Kathryn beckermannDepartment of medicineVanderbilt university medical centerDivision of hematology

Dr Binod Dhakal: The Importance of Patient Monitoring With Cilta-Cel Treatment

In part 2 of our interview with Binod Dhakal, MD, he addresses how CARTITUDE-4 study findings help to advance the clinical understanding of ciltacabtagene autoleucel (cilta-cel) and the importance of vigilance and education on the treatment’s adverse effects.

Binod dhakalJanssen johnsonDivision of hematologyCollege of wisconsinMedical collegeCilta celCartitude 4